AVEO Oncology (AVEO) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts AVEO Hot Sheet
Join SI Premium – FREE
AVEO Oncology (NASDAQ: AVEO) reported Q4 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $17.93 million.
For earnings history and earnings-related data on AVEO Oncology (AVEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
